Pathophysiology & Triggers - The Reaction Ignition
- Type I (Immediate) Hypersensitivity: Initial exposure to an allergen prompts IgE antibody production. Subsequent exposure leads to allergen cross-linking of IgE on mast cells and basophils.
- Massive Mediator Release: This triggers degranulation, releasing pre-formed mediators like histamine and tryptase, causing vasodilation, increased vascular permeability, and smooth muscle spasm.

- Common Triggers:
- Foods: Peanuts, tree nuts, shellfish, milk
- Medications: Penicillin, NSAIDs, anesthetics
- Insect Stings: Bees, wasps, fire ants
- Other: Latex, exercise
⭐ Serum tryptase is a specific marker for mast cell activation and helps confirm an anaphylaxis diagnosis, peaking 1-2 hours post-reaction.
Clinical Presentation - Signs of System Shock
Symptoms manifest rapidly, often within 5-30 minutes of allergen exposure across multiple systems.
- Cutaneous (~90%):
- Urticaria (hives), diffuse pruritus
- Angioedema (swelling of lips, tongue, face)
- Respiratory:
- Dyspnea, wheezing (bronchospasm)
- Stridor, hoarseness (laryngeal edema)
- Cardiovascular:
- Hypotension (SBP < 90 mmHg or >30% drop)
- Tachycardia, dizziness, or syncope
- Gastrointestinal:
- Nausea, vomiting, abdominal cramps
⭐ Be aware: Cutaneous findings may be absent in up to 20% of cases, especially in rapid-onset, profound shock.
Diagnostic Criteria - Nailing the Diagnosis
- Diagnosis is clinical. Any 1 of the following 3 criteria confirms anaphylaxis.
- Confirmatory Test: Serum tryptase can confirm the diagnosis retrospectively; levels peak 1-2 hours after reaction onset.
⭐ Hypotension is not required for diagnosis. The most common presentations involve skin and respiratory symptoms without a drop in blood pressure.
Acute Management - The Epi‑sode Response
Immediate Action: ABCs & Epinephrine
-
FIRST-LINE: Intramuscular (IM) Epinephrine is critical.
- Adult Dose: 0.3-0.5 mg (1:1000 solution) into anterolateral thigh.
- Pediatric Dose: 0.01 mg/kg (max 0.3 mg).
- May repeat every 5-15 minutes.
-
ADJUNCTIVE THERAPY:
- Antihistamines: H1 blockers (Diphenhydramine) + H2 blockers (Ranitidine/Famotidine).
- Glucocorticoids: (Methylprednisolone) to prevent biphasic reactions.
- Supportive: IV fluids for refractory hypotension; nebulized albuterol for bronchospasm.
⭐ A biphasic reaction (symptom recurrence 1-72 hours after initial resolution without re-exposure) can occur in up to 20% of patients. Observation is key.
Biphasic & Refractory - The Second Wave
- Biphasic Anaphylaxis: Symptom recurrence 1-72 hours post-resolution without re-exposure to the allergen.
- Refractory Anaphylaxis: Persistent symptoms despite receiving ≥2 doses of epinephrine.
- Management: IV epinephrine drip. Consider glucagon for patients on beta-blockers.
- Disposition: Observe patients for 4-8 hours after complete symptom resolution to monitor for a potential second wave.
⭐ Corticosteroids are administered with the aim of preventing biphasic reactions, though evidence for efficacy is varied.
High‑Yield Points - ⚡ Biggest Takeaways
- Anaphylaxis is a Type I (IgE-mediated) hypersensitivity reaction; requires prior sensitization.
- Intramuscular epinephrine is the first-line, life-saving treatment and should never be delayed.
- Airway compromise (stridor, hoarseness) is a primary cause of death; secure the airway early.
- Biphasic reactions can occur 1-72 hours after apparent resolution; always observe patients.
- Aggressive IV fluids are critical to counter distributive shock from massive vasodilation.
- Adjunctive therapies (antihistamines, corticosteroids) treat symptoms but do not replace epinephrine.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app